Manuel Pharmaceuticals Private Limited
Produces chemicals, compounds, and pharmaceuticals since 2011 with headquarters in Delhi.
2011 | Delhi (India) | Active
Manuel Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.10 M
- Company Age 14 Year, 9 Days
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 6.65 M
- Revenue Growth 58.10%
- Profit Growth 86.24%
- Ebitda 92.53%
- Net Worth 73.66%
- Total Assets 34.99%
About Manuel Pharmaceuticals
Manuel Pharmaceuticals Private Limited (MPPL) is a Private Limited Indian Non-Government Company incorporated in India on 19 February 2011 and has a history of 14 years. Its registered office is in Delhi, India.
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹6.65 M.
Naveen Agarwal and Pankaj Agarwal serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U51397DL2011PTC214417
- Company No.
214417
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Feb 2011
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Chemicals and Materials
Pharma
Who are the key members and board of directors at Manuel Pharmaceuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Naveen Agarwal  | Director | 19-Feb-2011 | Current |
| Pankaj Agarwal | Director | 19-Feb-2011 | Current |
Financial Performance of Manuel Pharmaceuticals.
Manuel Pharmaceuticals Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 58.1% increase. The company also saw a substantial improvement in profitability, with a 86.24% increase in profit. The company's net worth Soared by an impressive increase of 73.66%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Manuel Pharmaceuticals?
In 2020, Manuel Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Naveen Buildtech Private Limited
Naveen Agarwal is a mutual person
Charges (Loans)
Open Charges
₹6.65 M
Satisfied Charges
₹0
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 0.67 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 02 Apr 2022 | Hdfc Bank Limited | ₹6.65 M | Open |
How Many Employees Work at Manuel Pharmaceuticals?
Unlock and access historical data on people associated with Manuel Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Manuel Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Manuel Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.